ECM
IONS icon

ExodusPoint Capital Management’s Ionis Pharmaceuticals IONS Stock Holding History

ExodusPoint Capital Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$17.1M Buy
227,084
+143,209
+171% +$11.3M 0.14% 131
2025
Q4 		$6.64M Sell
83,875
-68,250
-45% -$5.14M 0.05% 375
2025
Q3 		$9.95M Buy
+152,125
New +$7.43M 0.1% 205
2025
Q2 		– Sell
-26,261
Closed -$792K – 1704
2025
Q1 		$792K Buy
+26,261
New +$860K 0.01% 984
2024
Q3 		– Sell
-209,194
Closed -$9.97M – 1829
2024
Q2 		$9.97M Sell
209,194
-6,699
-3% -$275K 0.07% 256
2024
Q1 		$9.36M Buy
215,893
+192,409
+819% +$9.17M 0.07% 219
2023
Q4 		$1.19M Buy
+23,484
New +$1.12M 0.01% 750
2023
Q2 		– Sell
-265,330
Closed -$9.48M – 2044
2023
Q1 		$9.48M Sell
265,330
-39,060
-13% -$1.47M 0.08% 294
2022
Q4 		$11.5M Buy
304,390
+297,973
+4,643% +$12.5M 0.17% 140
2022
Q3 		$284K Sell
6,417
-31,173
-83% -$1.31M ﹤0.01% 1538
2022
Q2 		$1.39M Buy
+37,590
New +$1.42M 0.02% 941
2022
Q1 		– Sell
-19,788
Closed -$602K – 2410
2021
Q4 		$602K Buy
19,788
+11,615
+142% +$366K 0.01% 1304
2021
Q3 		$274K Buy
+8,173
New +$308K ﹤0.01% 1653
2020
Q4 		– Sell
-26,507
Closed -$1.26M – 2151
2020
Q3 		$1.26M Buy
+26,507
New +$1.47M 0.03% 592
2020
Q2 		– Sell
-5,934
Closed -$281K – 1891
2020
Q1 		$281K Buy
5,934
+1,280
+28% +$71.3K 0.02% 672
2019
Q4 		$281K Buy
+4,654
New +$277K 0.01% 1173
2019
Q2 		– Sell
-63,522
Closed -$5.16M – 1216
2019
Q1 		$5.16M Buy
63,522
+58,022
+1,055% +$3.74M 0.38% 46
2018
Q4 		$297K Buy
+5,500
New +$281K 0.02% 198

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ExodusPoint Capital Management's IONS Position: Q1 2026 in Review

ExodusPoint Capital Management increased its Ionis Pharmaceuticals (IONS) stake by 171% in Q1 2026, buying an estimated $11.3M and bringing the position to 227,084 shares worth $17.1M. The position accounts for 0.14% of the portfolio, ranked #131.

ExodusPoint Capital Management first reported a position in IONS in Q4 2018 and has held it in 18 quarters since. 493 funds tracked by Wall St. Rank hold IONS as of Q1 2026.

  • ExodusPoint Capital Management held 227,084 shares of Ionis Pharmaceuticals worth $17.1M as of Q1 2026.
  • ExodusPoint Capital Management bought 143,209 Ionis Pharmaceuticals shares in Q1 2026, an estimated $11.3M.
  • Ionis Pharmaceuticals made up 0.14% of ExodusPoint Capital Management's portfolio in Q1 2026, its #131 holding.
  • ExodusPoint Capital Management first reported a position in Ionis Pharmaceuticals in Q4 2018 and has held it in 18 quarters since.
  • 493 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q1 2026.

Based on ExodusPoint Capital Management's 13F filing for Q1 2026, filed 14 May 2026.